12 research outputs found

    Genetic mechanisms of critical illness in COVID-19.

    Get PDF
    Host-mediated lung inflammation is present1, and drives mortality2, in the critical illness caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with critical illness may identify mechanistic targets for therapeutic development3. Here we report the results of the GenOMICC (Genetics Of Mortality In Critical Care) genome-wide association study in 2,244 critically ill patients with COVID-19 from 208 UK intensive care units. We have identified and replicated the following new genome-wide significant associations: on chromosome 12q24.13 (rs10735079, P = 1.65 × 10-8) in a gene cluster that encodes antiviral restriction enzyme activators (OAS1, OAS2 and OAS3); on chromosome 19p13.2 (rs74956615, P = 2.3 × 10-8) near the gene that encodes tyrosine kinase 2 (TYK2); on chromosome 19p13.3 (rs2109069, P = 3.98 ×  10-12) within the gene that encodes dipeptidyl peptidase 9 (DPP9); and on chromosome 21q22.1 (rs2236757, P = 4.99 × 10-8) in the interferon receptor gene IFNAR2. We identified potential targets for repurposing of licensed medications: using Mendelian randomization, we found evidence that low expression of IFNAR2, or high expression of TYK2, are associated with life-threatening disease; and transcriptome-wide association in lung tissue revealed that high expression of the monocyte-macrophage chemotactic receptor CCR2 is associated with severe COVID-19. Our results identify robust genetic signals relating to key host antiviral defence mechanisms and mediators of inflammatory organ damage in COVID-19. Both mechanisms may be amenable to targeted treatment with existing drugs. However, large-scale randomized clinical trials will be essential before any change to clinical practice

    ConSLAM: Periodically Collected Real-World Construction Dataset for SLAM and Progress Monitoring

    Get PDF
    Hand-held scanners are progressively adopted to workflows on con- struction sites. Yet, they suffer from accuracy problems, preventing them from deployment for demanding use cases. In this paper, we present a real-world dataset collected periodically on a construction site to measure the accuracy of SLAM algorithms that mobile scanners utilize. The dataset contains time-synchronised and spatially registered images and LiDAR scans, inertial data and professional ground-truth scans. To the best of our knowledge, this is the first publicly available dataset which reflects the periodic need of scanning construction sites with the aim of accurate progress monitoring using a hand-held scanner.BP, GeoSLAM, Laing O’Rourke, Topcon, Trimble, EU Horizon 2020 BIM2TWIN: Optimal Construction Management & Production Control project under an agreement No. 958398

    ConSLAM: Construction Data Set for SLAM

    No full text
    International audienceThis paper presents a dataset collected periodically on a construction site. The dataset aims to evaluate the performance of SLAM algorithms used by mobile scanners or autonomous robots. It includes ground-truth scans of a construction site collected using a terrestrial laser scanner along with five sequences of spatially registered and time-synchronized images, LiDAR scans and inertial data coming from our prototypical hand-held scanner. We also recover the ground-truth trajectory of the mobile scanner by registering the sequential LiDAR scans to the ground-truth scans and show how to use a popular software package to measure the accuracy of SLAM algorithms against our trajectory automatically. To the best of our knowledge, this is the first publicly accessible dataset consisting of periodically collected sequential data on a construction site

    Law and Development Lives On

    No full text

    Hybrid Nanoparticles for Detection and Treatment of Cancer

    No full text
    corecore